C40 -Malignant neoplasm of bone and articular cartilage of limbs
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C40 – N =1,015
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1995 | 29.8% | 21.1% | 1.8% | 7% | 40.4% | 57 |
1996 | 17.9% | 14.3% | 0% | 26.8% | 41.1% | 56 |
1997 | 26.8% | 17.9% | 0% | 14.3% | 41.1% | 56 |
1998 | 28.8% | 22% | 0% | 11.9% | 37.3% | 59 |
1999 | 20.7% | 13.8% | 3.4% | 20.7% | 41.4% | 58 |
2000 | 12.3% | 12.3% | 5.3% | 15.8% | 54.4% | 57 |
2001 | 21.2% | 15.4% | 5.8% | 9.6% | 48.1% | 52 |
2002 | 27.1% | 15.3% | 0% | 18.6% | 39% | 59 |
2003 | 28.6% | 14.3% | 2.4% | 11.9% | 42.9% | 42 |
2004 | 13.3% | 20% | 2.2% | 2.2% | 62.2% | 45 |
2005 | 26.8% | 24.4% | 4.9% | 9.8% | 34.1% | 41 |
2006 | 22.4% | 17.2% | 3.4% | 34.5% | 22.4% | 58 |
2007 | 18.8% | 25% | 2.1% | 22.9% | 31.3% | 48 |
2008 | 27.7% | 17% | 0% | 17% | 38.3% | 47 |
2009 | 17.4% | 23.9% | 0% | 23.9% | 34.8% | 46 |
2010 | 26.1% | 30.4% | 4.3% | 19.6% | 19.6% | 46 |
2011 | 31.1% | 24.4% | 0% | 17.8% | 26.7% | 45 |
2012 | 17.7% | 24.2% | 0% | 8.1% | 50% | 62 |
2013 | 25% | 15.9% | 2.3% | 9.1% | 47.7% | 44 |
2014 | 45.9% | 24.3% | 0% | 5.4% | 24.3% | 37 |